Posts

Showing posts from January, 2019

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Women in Business: Dr. Saema Mirza, Dr. Anu Rao, Dr. Joyce Koppang - Cardiovascular Associates - Hoover Sun

Women in Business: Dr. Saema Mirza, Dr. Anu Rao, Dr. Joyce Koppang - Cardiovascular Associates    Hoover Sun Cardiovascular Associates was founded in 1946 by Dr. John Burrett, the first cardiologist to practice in the state of Alabama. Now, 71 years later, CVA continues ...

Actelion (ALIOF) & China Jo-Jo Drugstores (CJJD) Critical Comparison - Fairfield Current

Actelion (ALIOF) & China Jo-Jo Drugstores (CJJD) Critical Comparison    Fairfield Current Actelion (OTCMKTS:ALIOF) and China Jo-Jo Drugstores (NASDAQ:CJJD) are both medical companies, but which is the better business? We will contrast the ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours' - Face2Face Africa

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

PAH Survival May Increase Risk for Pulmonary Artery Aneurysms - Pulmonology Advisor

PAH Survival May Increase Risk for Pulmonary Artery Aneurysms    Pulmonology Advisor The time course of pulmonary arterial hypertension was an independent risk factor for pulmonary artery aneurysms.

Johnson: I never met Larry Langford, but wish I had - AL.com

Johnson: I never met Larry Langford, but wish I had    AL.com Larry Langord is finally home. And his 'fro is tight., Love him or not, you can;t be mad at that.

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS) - ProHealth

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS)    ProHealth ME/CFS is not deconditioning nor are its symptoms explained by inactivity. The debility in ME/CFS is much greater than is seen with deconditioning The ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Q3 2018 Sentiment for Aveo Pharmaceuticals Inc (NASDAQ:AVEO) at 1.53 - Z Tribune

Q3 2018 Sentiment for Aveo Pharmaceuticals Inc (NASDAQ:AVEO) at 1.53    Z Tribune In Q3 2018 Aveo Pharmaceuticals Inc (NASDAQ:AVEO) big money sentiment decreased to 1.53, SEC filings reveal. That's down -0.58, from 2018Q2's 2.11.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds - Pulmonary Hypertension News

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds    Pulmonary Hypertension News Repeated measurements of different biomarkers over time offers better risk prediction than single measurements for PAH-CHD, a study says.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release - Digital Journal

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release    Digital Journal MRFR is the Leading Brand in The Research Company who Recently Published Medical Suction Device Market Research Reports which includes Study of ...

Living healthy in 2019! - Journal Advocate

Living healthy in 2019!    Journal Advocate January often brings New Year's Resolutions. One of the best resolutions is to live healthier this year than one did in the past year.

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - BioSpace

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    BioSpace Published: Jan 09, 2019. LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma - Edmond Sun

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma    Edmond Sun Telehealth is a program that is used nationwide to assist patients with their health care while they are at home. At the Eastern Oklahoma VA Health Care System, ...

Vectura Group (LON:VEC) Research Coverage Started at Numis Securities - PressOracle

Vectura Group (LON:VEC) Research Coverage Started at Numis Securities    PressOracle Numis Securities initiated coverage on shares of Vectura Group (LON:VEC) in a report issued on Thursday, January 3rd. The brokerage issued a buy rating and ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release - Digital Journal

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release    Digital Journal MRFR is the Leading Brand in The Research Company who Recently Published Medical Suction Device Market Research Reports which includes Study of ...

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release - Digital Journal

Medical Suction Device Market to Garner Significant Traction by 2023; Declares MRFR - Press Release    Digital Journal MRFR is the Leading Brand in The Research Company who Recently Published Medical Suction Device Market Research Reports which includes Study of ...

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair? - Pulmonology Advisor

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?    Pulmonology Advisor In patients undergoing transcatheter mitral valve repair (TMVR) with the Mitraclip device, pre-existing pulmonary hypertension (PH) is not associated with ...

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS) - ProHealth

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS)    ProHealth ME/CFS is not deconditioning nor are its symptoms explained by inactivity. The debility in ME/CFS is much greater than is seen with deconditioning The ...

Living healthy in 2019! - Journal Advocate

Living healthy in 2019!    Journal Advocate January often brings New Year's Resolutions. One of the best resolutions is to live healthier this year than one did in the past year.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Beware of Natural Supplements for Losing Weight and Improving Sex - Newsweek

Beware of Natural Supplements for Losing Weight and Improving Sex    Newsweek Many consumers consider dietary supplements to be natural and, therefore, safe. In fact, the Council for Responsible Nutrition reported in 2017 that 87 percent ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair? - Pulmonology Advisor

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?    Pulmonology Advisor In patients undergoing transcatheter mitral valve repair (TMVR) with the Mitraclip device, pre-existing pulmonary hypertension (PH) is not associated with ...

Deposit four-year-old awaits heart transplant in NYC - WBNG-TV

Deposit four-year-old awaits heart transplant in NYC    WBNG-TV The wait for a new heart has now passed 100 days for Jackson Vandermark, who was admitted to Morgan Stanley Children's Hospital in New York City on ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market - AlgosOnline

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market    AlgosOnline Market Study Reports recently added a detailed market research study focused on the Global Chronic Thromboembolic Pulmonary Hypertension Market across ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

10 medical tech innovations to ring in the New Year - MD Linx

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair? - Pulmonology Advisor

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?    Pulmonology Advisor In patients undergoing transcatheter mitral valve repair (TMVR) with the Mitraclip device, pre-existing pulmonary hypertension (PH) is not associated with ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Deposit four-year-old awaits heart transplant in NYC - WBNG-TV

Deposit four-year-old awaits heart transplant in NYC    WBNG-TV The wait for a new heart has now passed 100 days for Jackson Vandermark, who was admitted to Morgan Stanley Children's Hospital in New York City on ...

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market - AlgosOnline

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market    AlgosOnline Market Study Reports recently added a detailed market research study focused on the Global Chronic Thromboembolic Pulmonary Hypertension Market across ...

Pulmonary Hypertension Drug Market 2019-2024 Depth Analysis By Novartis AG, Merck & Co., Abbott Laboratories, AstraZeneca plc - Bitcoin Journal

Pulmonary Hypertension Drug Market 2019-2024 Depth Analysis By Novartis AG, Merck & Co., Abbott Laboratories, AstraZeneca plc    Bitcoin Journal Global Pulmonary Hypertension Drug Market 2019 – 2024 SWAT Analysis. Global Pulmonary Hypertension Drug Market Research report presents a ...

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

10 medical tech innovations to ring in the New Year - MD Linx

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

Addison's disease raises ischemic heart disease risk in women - Healio

Addison's disease raises ischemic heart disease risk in women    Healio Swedish women with Addison's disease are more likely to develop ischemic heart disease than healthy adults or men with the condition, whereas both men and ...

Beware of Natural Supplements for Losing Weight and Improving Sex - Newsweek

Beware of Natural Supplements for Losing Weight and Improving Sex    Newsweek Many consumers consider dietary supplements to be natural and, therefore, safe. In fact, the Council for Responsible Nutrition reported in 2017 that 87 percent ...

Living healthy in 2019! - Journal Advocate

Living healthy in 2019!    Journal Advocate January often brings New Year's Resolutions. One of the best resolutions is to live healthier this year than one did in the past year.

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS) - ProHealth

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS)    ProHealth ME/CFS is not deconditioning nor are its symptoms explained by inactivity. The debility in ME/CFS is much greater than is seen with deconditioning The ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Deposit four-year-old awaits heart transplant in NYC - WBNG-TV

Deposit four-year-old awaits heart transplant in NYC    WBNG-TV The wait for a new heart has now passed 100 days for Jackson Vandermark, who was admitted to Morgan Stanley Children's Hospital in New York City on ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

In HFrEF, women face poorer quality of life, receive less treatment vs. men - Healio

In HFrEF, women face poorer quality of life, receive less treatment vs. men    Healio Women with HF with reduced ejection fraction live longer than men diagnosed with HFrEF but live a poorer quality of life with greater self-reported psychological ...

10 medical tech innovations to ring in the New Year - MD Linx

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Use natural ways - Zambia Daily Mail

Use natural ways    Zambia Daily Mail ZAMBIAN men should heed the timely and life-saving warning by the Zambia Medical Association of Zambia (ZMA) that those in the habit of using sex-boosting ...

10 medical tech innovations to ring in the New Year - MD Linx

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

Use natural ways - Zambia Daily Mail

Use natural ways    Zambia Daily Mail ZAMBIAN men should heed the timely and life-saving warning by the Zambia Medical Association of Zambia (ZMA) that those in the habit of using sex-boosting ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel - Odessa American

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel    Odessa American RESEARCH TRIANGLE PARK, N.C. & TORONTO--(BUSINESS WIRE)--Jan 3, 2019--Analytics 4 Life, a digital health company dedicated to improving existing ...

Pulmonary therapy breaks cycle of frequent lung infections - Florida Today

Pulmonary therapy breaks cycle of frequent lung infections    Florida Today People with pulmonary disease have more bouts of lung infections and bronchitis than the general population.

Beware of Natural Supplements for Losing Weight and Improving Sex - Newsweek

Beware of Natural Supplements for Losing Weight and Improving Sex    Newsweek Many consumers consider dietary supplements to be natural and, therefore, safe. In fact, the Council for Responsible Nutrition reported in 2017 that 87 percent ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - BioSpace

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    BioSpace Published: Jan 09, 2019. LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be ...

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial - NEWSTAGE

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial    NEWSTAGE LIQ861 was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDA NDA submission targeted for late 2019.

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma - Pauls Valley Daily Democrat

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma    Pauls Valley Daily Democrat Telehealth is a program that is used nationwide to assist patients with their health care while they are at home. At the Eastern Oklahoma VA Health Care System, ...

A Decidedly Darker Prognosis for Takotsubo Syndrome - Medscape

A Decidedly Darker Prognosis for Takotsubo Syndrome    Medscape Takotsubo syndrome (TS) has been considered a transient benign disorder, but mounting evidence of a darker long-term prognosis is reshaping that belief.

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma - Pauls Valley Daily Democrat

Veteran Connection: Advantages of Telehealth Medicine | Oklahoma    Pauls Valley Daily Democrat Telehealth is a program that is used nationwide to assist patients with their health care while they are at home. At the Eastern Oklahoma VA Health Care System, ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume - Fairfield Current

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume    Fairfield Current Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares saw strong trading volume on Monday . 1671001 shares changed hands during mid-day trading, ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

The Challenge of Diagnosing Abdominal Pain and Diarrhea - MedPage Today

The Challenge of Diagnosing Abdominal Pain and Diarrhea    MedPage Today Distinguishing between the myriad causes of intestinal symptoms such as abdominal pain, bloating, and persistent diarrhea can be challenging, especially in ...

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Uptravi for PAH to receive NHS England funding 9 January 2019 - Zenopa

Uptravi for PAH to receive NHS England funding 9 January 2019    Zenopa Treatment for the rare and incurable disease pulmonary arterial hypertension, which affects approximately 3,000 people in the UK, has been available in all of ...

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours' - Face2Face Africa

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

The Challenge of Diagnosing Abdominal Pain and Diarrhea - MedPage Today

The Challenge of Diagnosing Abdominal Pain and Diarrhea    MedPage Today Distinguishing between the myriad causes of intestinal symptoms such as abdominal pain, bloating, and persistent diarrhea can be challenging, especially in ...

Johnson: I never met Larry Langford, but wish I had - AL.com

Johnson: I never met Larry Langford, but wish I had    AL.com Larry Langord is finally home. And his 'fro is tight., Love him or not, you can;t be mad at that.

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

Beware of Natural Supplements for Losing Weight and Improving Sex - Newsweek

Beware of Natural Supplements for Losing Weight and Improving Sex    Newsweek Many consumers consider dietary supplements to be natural and, therefore, safe. In fact, the Council for Responsible Nutrition reported in 2017 that 87 percent ...

Team PHenomenal Hope Accepting Applications for Research Grants - Pulmonary Hypertension News

Team PHenomenal Hope Accepting Applications for Research Grants    Pulmonary Hypertension News To better the lives of pulmonary hypertension (PH) patients, Team PHenomenal Hope is taking applications for early-career research grants of up to $50000.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds - Pulmonary Hypertension News

Repeated Measurements of Biomarkers May Improve Prognostic Accuracy in PAH-CHD Patients, Study Finds    Pulmonary Hypertension News Repeated measurements of different biomarkers over time offers better risk prediction than single measurements for PAH-CHD, a study says.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours' - Face2Face Africa

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

Johnson: I never met Larry Langford, but wish I had - AL.com

Johnson: I never met Larry Langford, but wish I had    AL.com Larry Langord is finally home. And his 'fro is tight., Love him or not, you can;t be mad at that.

Elaine Pagels' Dallas event sells out, but you can still read her moving memoir, 'Why Religion?' - Dallas News

Elaine Pagels' Dallas event sells out, but you can still read her moving memoir, 'Why Religion?'    Dallas News Editor's note: Elaine Pagels, who canceled her Nov. 11 appearance in Dallas because of illness, will speak 2:30 p.m. Sunday, Jan. 6 at a sold-out Arts & Letters ...

Adamis Files 2 NDAs And Upholds Pledge To Shareholders...Barely - Seeking Alpha

Adamis Files 2 NDAs And Upholds Pledge To Shareholders...Barely    Seeking Alpha CEO Dennis J. Carlo Ph. D was able to fulfill his pledge to investors to file NDAs for APC-8000 (tadalafil) and APC-6000 (naloxone) before year end. I provide b.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours' - Face2Face Africa

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Uptravi for PAH to receive NHS England funding 9 January 2019 - Zenopa

Uptravi for PAH to receive NHS England funding 9 January 2019    Zenopa Treatment for the rare and incurable disease pulmonary arterial hypertension, which affects approximately 3,000 people in the UK, has been available in all of ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Johnson: I never met Larry Langford, but wish I had - AL.com

Johnson: I never met Larry Langford, but wish I had    AL.com Larry Langord is finally home. And his 'fro is tight., Love him or not, you can;t be mad at that.

The Challenge of Diagnosing Abdominal Pain and Diarrhea - MedPage Today

The Challenge of Diagnosing Abdominal Pain and Diarrhea    MedPage Today Distinguishing between the myriad causes of intestinal symptoms such as abdominal pain, bloating, and persistent diarrhea can be challenging, especially in ...

Addison's disease raises ischemic heart disease risk in women - Healio

Addison's disease raises ischemic heart disease risk in women    Healio Swedish women with Addison's disease are more likely to develop ischemic heart disease than healthy adults or men with the condition, whereas both men and ...

Prescription drug Suhagra cause for Snapdeal and seller prosecution in Karnataka - MediaNama.com

Prescription drug Suhagra cause for Snapdeal and seller prosecution in Karnataka    MediaNama.com The Karnataka drugs controller will begin prosecution against executives of online marketplace Snapdeal, and an owner and staffer of Ludhiana-based retailer ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Team PHenomenal Hope Accepting Applications for Research Grants - Pulmonary Hypertension News

Team PHenomenal Hope Accepting Applications for Research Grants    Pulmonary Hypertension News To better the lives of pulmonary hypertension (PH) patients, Team PHenomenal Hope is taking applications for early-career research grants of up to $50000.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel - Odessa American

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel    Odessa American RESEARCH TRIANGLE PARK, N.C. & TORONTO--(BUSINESS WIRE)--Jan 3, 2019--Analytics 4 Life, a digital health company dedicated to improving existing ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours' - Face2Face Africa

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

Uptravi for PAH to receive NHS England funding 9 January 2019 - Zenopa

Uptravi for PAH to receive NHS England funding 9 January 2019    Zenopa Treatment for the rare and incurable disease pulmonary arterial hypertension, which affects approximately 3,000 people in the UK, has been available in all of ...

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume - Fairfield Current

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume    Fairfield Current Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares saw strong trading volume on Monday . 1671001 shares changed hands during mid-day trading, ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - BioSpace

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    BioSpace Published: Jan 09, 2019. LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be ...

Global Prostacyclin Market Will Grow at a CAGR 5.5% and Reach USD 2.42 Billion by 2023, from USD 1.76 Billion in 2017 - Press Release - Digital Journal

Global Prostacyclin Market Will Grow at a CAGR 5.5% and Reach USD 2.42 Billion by 2023, from USD 1.76 Billion in 2017 - Press Release    Digital Journal New Global Prostacyclin Consumption Market 2023 Report Covers market forecast and top Companies like United Therapeutics, Actelion (J & J), GSK, Teva, ...

The Challenge of Diagnosing Abdominal Pain and Diarrhea - MedPage Today

The Challenge of Diagnosing Abdominal Pain and Diarrhea    MedPage Today Distinguishing between the myriad causes of intestinal symptoms such as abdominal pain, bloating, and persistent diarrhea can be challenging, especially in ...

EMA Handed Down Fewer Positive Drug Opinions in 2018 - Medscape

EMA Handed Down Fewer Positive Drug Opinions in 2018    Medscape The Committee for Medicinal Products for Human Use granted 84 positive opinions for new medicines in 2018, including 42 agents with a new active substance ...

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial - Associated Press

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial    Associated Press LIQ861was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDA -- NDA submission targeted for late 2019 ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

Medical Insurance Plans That Cover Critical Illnesses: All You Need To Know - NDTV News

Medical Insurance Plans That Cover Critical Illnesses: All You Need To Know    NDTV News Protection against critical illness can be taken up in two ways: as a standalone policy, or as a rider with a medical/life insurance plan.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Uptravi for PAH to receive NHS England funding 9 January 2019 - Zenopa

Uptravi for PAH to receive NHS England funding 9 January 2019    Zenopa Treatment for the rare and incurable disease pulmonary arterial hypertension, which affects approximately 3,000 people in the UK, has been available in all of ...

EMA Handed Down Fewer Positive Drug Opinions in 2018 - Medscape

EMA Handed Down Fewer Positive Drug Opinions in 2018    Medscape The Committee for Medicinal Products for Human Use granted 84 positive opinions for new medicines in 2018, including 42 agents with a new active substance ...

NICE 2018 Guideline on diagnosis of COPD - Specialty Medical Dialogues

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

FDA Approves Sprycel for Pediatric ALL - Curetoday.com

FDA Approves Sprycel for Pediatric ALL    Curetoday.com The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed ...

Breast-Conserving Surgery Can Improve Quality of Life in Breast Cancer Survivors - Curetoday.com

Breast-Conserving Surgery Can Improve Quality of Life in Breast Cancer Survivors    Curetoday.com For young breast cancer survivors, the type of surgery they recieve to treat their disease can impact their quality of life, according to recent research.

Vectura Group (VEC) Received Hold Rating at Shore Capital - BharataPress

Vectura Group (VEC) Received Hold Rating at Shore Capital    BharataPress Vectura Group (LON:VEC)'s stock had its “hold” rating reiterated by Shore Capital in a research note issued to investors on Thursday.

Arena Pharmaceuticals (ARNA) Shares Up 6.9% - Fairfield Current

Arena Pharmaceuticals (ARNA) Shares Up 6.9%    Fairfield Current Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shot up 6.9% on Monday . The company traded as high as $43.95 and last traded at $43.77. 783698 ...

Beware of natural supplements for sex gain and weight loss - AlterNet

Beware of natural supplements for sex gain and weight loss    AlterNet Many consumers consider dietary supplements to be natural and, therefore, safe. In fact, the Council for Responsible Nutrition reported in 2017 that 87 percent ...

Contrasting ASTELLAS PHARMA/ADR (ALPMY) and Apricus Biosciences (APRI) - PressOracle

Contrasting ASTELLAS PHARMA/ADR (ALPMY) and Apricus Biosciences (APRI)    PressOracle Apricus Biosciences (NASDAQ:APRI) and ASTELLAS PHARMA/ADR (OTCMKTS:ALPMY) are both medical companies, but which is the superior stock? We will ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients - Pulmonary Hypertension News

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients    Pulmonary Hypertension News Read about a study indicating that factors such as worse cardiac function are associated with obstructive sleep apnea in patients with CTEPH.

2018: My Year in Review - Pulmonary Hypertension News

2018: My Year in Review    Pulmonary Hypertension News 2018 was triumphant. I accomplished several of my long-term goals. I had zero organ rejection, so I remained on my lowest dose of prednisone all year, and that ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

NICE 2018 Guideline on diagnosis of COPD - Specialty Medical Dialogues

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients - Pulmonary Hypertension News

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients    Pulmonary Hypertension News Read about a study indicating that factors such as worse cardiac function are associated with obstructive sleep apnea in patients with CTEPH.

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial - Associated Press

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial    Associated Press LIQ861was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDA -- NDA submission targeted for late 2019 ...

NHS England to fund Actelion's Uptravi - PharmaTimes

NHS England to fund Actelion's Uptravi    PharmaTimes Actelion has announced that NHS patients in England, who have the rare, incurable and devastating disease pulmonary arterial hypertension (PAH) can now be ...

Adamis Files 2 NDAs And Upholds Pledge To Shareholders...Barely - Seeking Alpha

Adamis Files 2 NDAs And Upholds Pledge To Shareholders...Barely    Seeking Alpha CEO Dennis J. Carlo Ph. D was able to fulfill his pledge to investors to file NDAs for APC-8000 (tadalafil) and APC-6000 (naloxone) before year end. I provide b.

New tech helps patients find rest | Local News - El Paso Inc.

New tech helps patients find rest | Local News    El Paso Inc. A new implant device, no bigger than a potato chip, that has been changing the lives of Americans who suffer from sleep apnea, is now available in El Paso.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

2018: My Year in Review - Pulmonary Hypertension News

2018: My Year in Review    Pulmonary Hypertension News 2018 was triumphant. I accomplished several of my long-term goals. I had zero organ rejection, so I remained on my lowest dose of prednisone all year, and that ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Venous Thromboembolism Treatment Market Size, Share, Type with Sanofi-Aventis, Upsher-Smith Laboratories - Find Market Research By Abhishek Budholiya

Venous Thromboembolism Treatment Market Size, Share, Type with Sanofi-Aventis, Upsher-Smith Laboratories    Find Market Research By Abhishek Budholiya Venous Thromboembolism (VTE) is formation of blood clot in the vein. It includes both Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). When a clot ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients - Pulmonary Hypertension News

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients    Pulmonary Hypertension News Read about a study indicating that factors such as worse cardiac function are associated with obstructive sleep apnea in patients with CTEPH.

NHS England to fund Actelion's Uptravi - PharmaTimes

NHS England to fund Actelion's Uptravi    PharmaTimes Actelion has announced that NHS patients in England, who have the rare, incurable and devastating disease pulmonary arterial hypertension (PAH) can now be ...

NICE 2018 Guideline on diagnosis of COPD - Specialty Medical Dialogues

NICE 2018 Guideline on diagnosis of COPD    Specialty Medical Dialogues NICE has released its updated 2018 guidelines on diagnosis of Chronic obstructive pulmonary disease in over 16s.COPD is a common, preventable and ...

2018: My Year in Review - Pulmonary Hypertension News

2018: My Year in Review    Pulmonary Hypertension News 2018 was triumphant. I accomplished several of my long-term goals. I had zero organ rejection, so I remained on my lowest dose of prednisone all year, and that ...

The organization helping to bring new drugs for rare diseases to market - ABC News

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis - Pulmonology Advisor

Patient Age Linked With Specific PAH Clinical Profile and Prognosis    Pulmonology Advisor Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.